AR and Alzheimer disease: Interestingly, however, the AD group shows the highest prevalence of variants at protein interfaces (31%), compared to 27% for AR and 20% for gnomAD, hinting at the importance of intermolecular interactions for understanding alternate molecular disease mechanisms.